factually
Index/Topics/Ivermectin Cancer Treatment

Ivermectin Cancer Treatment

Ivermectin as a potential treatment for cancer, specifically metastatic triple-negative breast cancer (TNBC), with a focus on a phase I/II clinical trial (NCT05318469) combining ivermectin with anti-PD-1 immunotherapy.

Fact-Checks

2 results
Jan 17, 2026
Most Viewed

What randomized clinical trials of ivermectin in cancer are currently registered and what are their designs and endpoints?

Only a single actively registered randomized or early-phase trial of ivermectin in human cancer patients is clearly documented in the available reporting: a phase I/II study combining oral ivermectin ...

Jan 5, 2026

What are the medically approved human uses and dosing guidelines for ivermectin in 2025?

Ivermectin in 2025 is a well-established antiparasitic medicine with specific, approved human indications and weight‑based dosing regimens; it is not approved for COVID‑19 or cancer and can be dangero...